Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8739)
All Articles published online
|
Publishing Process of This Article
|
Dec 10, 2014 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pavlidou A, Kroupis C, Dimas K. Association of survivin splice variants with prognosis and treatment of breast cancer. World J Clin Oncol 2014; 5(5): 883-894 [PMID: 25493226 DOI: 10.5306/wjco.v5.i5.883] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i5/883.htm |
| Number | Citing Articles |
| 1 |
Esra Esmeray Sönmez, Tevfik Hatipoğlu, Deniz Kurşun, Xiaozhou Hu, Burcu Akman, Hongling Yuan, Ayça Erşen Danyeli, İnci Alacacıoğlu, Sermin Özkal, Aybüke Olgun, Taner Kemal Erdağ, Hua You, Can Küçük. Whole Transcriptome Sequencing Reveals Cancer-Related, Prognostically Significant Transcripts and Tumor-Infiltrating Immunocytes in Mantle Cell Lymphoma. Cells 2022; 11(21): 3394 doi: 10.3390/cells11213394
|
| 2 |
Mohammad-Reza Mahmoudian-Sani, Arash Alghasi, Ali Saeedi-Boroujeni, Akram Jalali, Mohammad Jamshidi, Ali Khodadadi. Survivin as a diagnostic and therapeutic marker for thyroid cancer. Pathology - Research and Practice 2019; 215(4): 619 doi: 10.1016/j.prp.2019.01.025
|
| 3 |
Rama N. Behera, Vinod S. Bisht, Kuldeep Giri, Kiran Ambatipudi. Realm of proteomics in breast cancer management and drug repurposing to alleviate intricacies of treatment. PROTEOMICS – Clinical Applications 2023; 17(6) doi: 10.1002/prca.202300016
|
| 4 |
Ludovica Taglieri, Francesca De Iuliis, Anna Giuffrida, Sabrina Giantulli, Ida Silvestri, Susanna Scarpa. Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells. Oncology Letters 2017; 14(3): 3832 doi: 10.3892/ol.2017.6597
|
| 5 |
Joji Iida, Elisabeth T. Bell-Loncella, Marc L. Purazo, Yifeng Lu, Jesse Dorchak, Rebecca Clancy, Julianna Slavik, Mary Lou Cutler, Craig D. Shriver. Inhibition of cancer cell growth by ruthenium complexes. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-0797-9
|
| 6 |
Abdollah Jafarzadeh, Nasrin Bazargan, Nazanin Chatrabnous, Sara Jafarzadeh, Maryam Nemati. Contribution of survivin to the immune system, allergies and autoimmune diseases. Human Immunology 2023; 84(4): 301 doi: 10.1016/j.humimm.2023.01.009
|
| 7 |
Nancy Martínez-Montiel, Maricruz Anaya-Ruiz, Martín Pérez-Santos, Rebeca Martínez-Contreras. Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools. Genes 2017; 8(10): 217 doi: 10.3390/genes8100217
|
| 8 |
Glaucia Luciano da Veiga, Raissa Daniel Machado da Silva, Edimar Cristiano Pereira, Ligia Ajaime Azzalis, Beatriz da Costa Aguiar Alves, Flavia de Sousa Gehrke, Thaís Moura Gascón, Fernando Luiz Affonso Fonseca. The role of Survivin as a biomarker and potential prognostic factor for breast cancer. Revista da Associação Médica Brasileira 2019; 65(6): 893 doi: 10.1590/1806-9282.65.6.893
|
| 9 |
E. E. Bashmakova, N. S. Panamarev, A. N. Kudryavtsev, D. V. Chernyaev, E. V. Slepov, R. A. Zukov, L. A. Frank. Relationship of -31G/C (rs9904341) polymorphism in the survivin gene <i>BIRC5</i> and the risk of bladder cancer. Siberian journal of oncology 2022; 21(4): 64 doi: 10.21294/1814-4861-2022-21-4-64-71
|
| 10 |
Matthew M. Yeh, Sarag Boukhar, Benjamin Roberts, Nairanjana Dasgupta, Sayed S. Daoud. Genomic variants link to hepatitis C racial disparities. Oncotarget 2017; 8(35): 59455 doi: 10.18632/oncotarget.19755
|
| 11 |
Brian J. Czerniecki, Nadia Nocera, Lea Lowenfeld, Lori Showalter, Gary Koski. Trends in Breast Cancer Prevention. 2016; : 253 doi: 10.1007/978-3-319-27135-4_10
|
| 12 |
Xiao-Zhou Liu, Cheng-Jun Li, Su-Jia Wu, Xin Shi, Jian-Ning Zhao. Involvement of α5 integrin in survivin-mediated osteosarcoma metastasis. Asian Pacific Journal of Tropical Medicine 2016; 9(5): 478 doi: 10.1016/j.apjtm.2016.03.022
|
| 13 |
Neerada Meenakshi Warrier, Prasoon Agarwal, Praveen Kumar. Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics. Stem Cell Reviews and Reports 2020; 16(5): 828 doi: 10.1007/s12015-020-09995-4
|
| 14 |
Christiana M. Neophytou, Avgoustinos Mesaritis, Gregoria Gregoriou, Andreas I. Constantinou. d-a-Tocopheryl Polyethylene Glycol 1000 Succinate and a small-molecule Survivin suppressant synergistically induce apoptosis in SKBR3 breast cancer cells. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-50884-9
|
| 15 |
Zhu-Qing Liu, Ying-Chao Han, Jue-Min Fang, Fei Hu, Xi Zhang, Qing Xu. WITHDRAWN: Hypoxia-induced STAT3 contributes to chemoresistance and epithelial–mesenchymal transition in prostate cancer cells. Biochemical and Biophysical Research Communications 2015; doi: 10.1016/j.bbrc.2015.02.027
|
| 16 |
Efsun Eren-Keleş, Halil Gürhan Karabulut, Hasan Fatih Çakmaklı, Başak Adaklı, Serdar Kenan Köse, Handan Uğur-Dinçaslan, Gülsan Yavuz, Mehmet Ertem, Ajlan Tükün. Expression of Survivin and Its Splice Variants in Pediatric Acute Lymphoblastic Leukemia. Genetic Testing and Molecular Biomarkers 2018; 22(12): 680 doi: 10.1089/gtmb.2018.0152
|
| 17 |
Vladimir N. Uversky. (Intrinsically disordered) splice variants in the proteome: implications for novel drug discovery. Genes & Genomics 2016; 38(7): 577 doi: 10.1007/s13258-015-0384-0
|
| 18 |
Eman El Zeneini, Sarah Kamel, Mahmoud El-Meteini, Asma Amleh. Knockdown of COBRA1 decreases the proliferation and migration of hepatocellular carcinoma cells. Oncology Reports 2017; 37(3): 1896 doi: 10.3892/or.2017.5390
|
| 19 |
Qiang Wang, Mark I. Greene. Survivin as a Therapeutic Target for the Treatment of Human Cancer. Cancers 2024; 16(9): 1705 doi: 10.3390/cancers16091705
|
| 20 |
Giuseppe Siragusa, Laura Tomasello, Carla Giordano, Giuseppe Pizzolanti. Survivin (BIRC5): Implications in cancer therapy. Life Sciences 2024; 350: 122788 doi: 10.1016/j.lfs.2024.122788
|
| 21 |
Minna Turkkila, Karin M.E. Andersson, Sylvie Amu, Mikael Brisslert, Malin C. Erlandsson, Sofia Silfverswärd, Maria I. Bokarewa. Suppressed diversity of survivin splicing in active rheumatoid arthritis. Arthritis Research & Therapy 2015; 17(1) doi: 10.1186/s13075-015-0689-z
|
| 22 |
Matthew Brown, Wanbin Zhang, Deyue Yan, Rajath Kenath, Le Le, He Wang, Daniel Delitto, David Ostrov, Keith Robertson, Chen Liu, Kien Pham, Andrei L. Gartel. The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC. PLOS ONE 2020; 15(1): e0226917 doi: 10.1371/journal.pone.0226917
|
| 23 |
Qi Xie, Qiulian Wu, Stephen C. Mack, Kailin Yang, Leo Kim, Christopher G. Hubert, William A. Flavahan, Chengwei Chu, Shideng Bao, Jeremy N. Rich. CDC20 maintains tumor initiating cells. Oncotarget 2015; 6(15): 13241 doi: 10.18632/oncotarget.3676
|
| 24 |
Jerry Xiao, Joseph R. McGill, Apsra Nasir, Alexander Lekan, Bailey Johnson, Devan J. Wilkins, Gray W. Pearson, Kandice Tanner, Hani Goodarzi, Eric Glasgow, Richard Schlegel, Seema Agarwal. Identifying drivers of breast cancer metastasis in progressively invasive subpopulations of zebrafish-xenografted MDA-MB-231. Molecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-022-00080-5
|
| 25 |
Javier Gaytan-Cervantes, Carolina Gonzalez-Torres, Vilma Maldonado, Cecilia Zampedri, Gisela Ceballos-Cancino, Jorge Melendez-Zajgla. Protein Sam68 regulates the alternative splicing of survivin DEx3. Journal of Biological Chemistry 2017; 292(33): 13745 doi: 10.1074/jbc.M117.800318
|